---
title: "Home"
site: workflowr::wflow_site
output:
  workflowr::wflow_html:
    toc: false
editor_options:
  chunk_output_type: console
mainfont: {Arial Unicode MS}
---

```{r setup, include=FALSE}
knitr::asis_output("\U207A","\U2212")
```

### **NSCLC** : 


**Figure 1 and Supplementary Figure 2**

* Characterize stroma cells (CD90`r knitr::asis_output("\U207A")` and CD90`r knitr::asis_output("\U2212")` fibroblasts and endothelial cells (EC) and primarily focus on CCL19`r knitr::asis_output("\U207A")` fibroblasts : [NSCLC_stroma_CCCL19_FRC.html](NSCLC_stroma_CCCL19_FRC.html)  

* Compare NSCLC CCL19 FRCs with Tonsilar FRCs :
[NSCLC_vs_Tonsils.html](NSCLC_vs_Tonsils.html)


**Figure 3 and Supplementary Figure 4**

* Characterize and visualize Tumor infiltrating lymphocytes (TILs), with a focus on CD8`r knitr::asis_output("\U207A")` T cell subsets : [NSCLC_TILS.html](NSCLC_TILS.html)

* Combine NSCLS CCL19`r knitr::asis_output("\U207A")` FRCs and NSCLS TILs (special focus on CD8`r knitr::asis_output("\U207A")` T cells ) and perform interactome analysis to determine significant signaling L-R pairs and genes involved : [merge_NSCLC_FRC_TIL.html](merge_NSCLC_FRC_TIL.html)


**Figure 4 and Supplementary Figure 5**

* NSCLC differentiation: 


### **Murine Lung Tumors** :


**Figure 5 and Supplementary Figure 6**

* Characterize CCL19-EYFP`r knitr::asis_output("\U207A")` cell data from na√Øve lungs and excised LLC-gp33 tumors on day 23 : [Mouse_LLC_naive.html](Mouse_LLC_naive.html)


**Figure 6 and Supplementary Figure 7**

* Characterize CCL19-EYFP`r knitr::asis_output("\U207A")` FRC subsets in coronavirus-vector based immunotherapy : [Mouse_mCOV.html](Mouse_mCOV.html)




